Objective To comprehend the situation of insulin and insulin analogue usage in the recent 5 years. Methods The species, dosage, amount of money and DDDs of insulin and insulin analogue in the hospital in 2010-2014 were analyzed. Results The con-sumption cost of insulin and insulin analogue increases 22. 04% yearly. The amount of money of insulin glargine injection, isophane pro-tamine recombinant human insulin injection ( pre-mixed 30/70 ) and isophane protamine biosynthetic human insulin injection ( pre-mixed 3R ) were top three in the five years, accounting for more than 80%. The DDDs of these were also top three in the past five years, ac-counting for more than 50%. Conclusion The insulin and insulin analogue is widely used in the hospital. The dosage and amount of money are increased fast.%目的 探讨医院2010年至2014年胰岛素及其类似物的临床应用情况.方法 统计医院2010年至2014年胰岛素及其类似物的品种、销售金额、用药频度(DDDs).结果 胰岛素及其类似物的使用总金额逐年增长,平均年增长率为22.04%;甘精胰岛素、精蛋白重组人胰岛素预混30/70、精蛋白生物合成人胰岛素预混30R的使用金额5年均排在前3位,三者合计超过80%.普通胰岛素、精蛋白重组人胰岛素预混30/70与甘精胰岛素DDDs值5年始终位居前3位,三者合计超过50%.结论 医院胰岛素及其类似物临床应用广泛,使用量与金额均呈快速增长趋势.
展开▼
